Clinical Trial Update: Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a regimen of fludarabine, mitoxantrone, and rituximab in relapsed or primary failing advanced follicular lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Fludarabine (Fludarabine)
• Mitoxantrone (mitoxantrone)
• Rituximab (rituximab)

Snippet

Sponsor: Lymphoma Study Association | Conditions: Follicular Lymphoma | Phase 2 | Status: COMPLETED